Home / Research library / GHK-Cu
GHK-Cu: molecular data, studies & sources
GHK-Cu is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.
Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review
Molecular formula, weight & structure
- Molecular formula (MF)
- C14H23CuN6O4+
- Molecular weight (MW)
- 402.92 g/mol
- PubChem compound ID
- 71587328
- Record title
- Prezatide copper
The selected PubChem record is prezatide copper, a charged 1:1 copper complex. Other coordination, protonation, acetate and 2:1 representations have different formulas and molecular weights. This is not a universal specification for every product labeled GHK-Cu.
Source: PubChem CID 71587328 · retrieved 2026-09-21

Chemical identifiers and source data
- IUPAC name
- copper (2S)-6-amino-2-[[(2S)-2-[(2-aminoacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoate
- InChIKey
- NZWIFMYRRCMYMN-ACMTZBLWSA-M
- SMILES
- C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)[O-])NC(=O)CN.[Cu+2]
Identifiers
- PubChem CID
- 71587328
- CAS Registry Number
- 89030-95-5via ChemIDplus, EPA DSSTox
- InChIKey
- NZWIFMYRRCMYMN-ACMTZBLWSA-M
- Wikidata
- Q5168796
CAS numbers are published only from ChemIDplus, EPA DSSTox or the FDA Global Substance Registration System; UNII codes are confirmed in FDA GSRS by structure, sequence or exact name. Checked 2026-10-07.
Calculated molecular descriptors
| Monoisotopic (exact) mass | 402.1071 Da |
|---|---|
| Heavy atoms | 25 |
| Hydrogen-bond donors | 5 |
| Hydrogen-bond acceptors | 7 |
| Rotatable bonds | 11 |
| Topological polar surface area | 179.1 Ų |
| Calculated logP (Crippen) | -3.24 |
| Rings | 1 |
| Stereocenters | 2 |
| Formal charge | 1 |
Computed with RDKit from the published SMILES (Crippen logP, topological polar surface area). Calculated descriptors are not measured properties of a supplied batch.
Registered clinical trials
Studies registered on ClinicalTrials.gov that list GHK-Cu as an intervention. Studies that only measure the molecule as a biomarker, or use it only as a comparator or background arm for another drug, are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.
1 registered study matched, 1 currently active or recruiting.
- By highest phase
- Phase 2 · 1
- By registry status
- Recruiting · 1
| Study | Phase · status | Conditions | Sponsor · size |
|---|---|---|---|
| Topical GHK-Cu Gel for Acute Skin Wound HealingNCT07437586 · start 2026-02-02 · primary completion 2027-02-14 | Phase 2Recruiting | Acute Standardized Cutaneous Wounds (Punch-biopsy Wounds) | Hudson Biotech60 participants |
Registry check 2026-10-09 · Run this search on ClinicalTrials.gov
Human intervention studies
Selected studies in which participants received GHK-Cu, with their indexed or reviewed study type. Check the original article for the formulation, population and controls. Studies that only measured the molecule, or used it as a comparator, are listed separately below and are not counted as intervention studies.
No human study that administered this compound was retained in this selected bibliography. This is a documented evidence gap in our selection, not proof that no study exists.
Preclinical research, reviews & other publications
Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.
- Review · secondary evidence
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.
Pickart L, Margolina A · International journal of molecular sciences · 2018
PMID 29986520 · DOI: 10.3390/ijms19071987
GHK-Cu supplier sources
Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.
GHK-Cu for sale: compare prices, sizes and forms from every tracked supplier →
| Supplier | Recorded packages | Example source listing |
|---|---|---|
| American PeptidesUSD | 100mg Vial · 50mg Vial2 recorded offers | 100mg Vial · $75.00Checked Oct 13, 2026Supplier listing, GHK-Cu 100mg Vial, American Peptides, opens in a new tab |
| Blank PeptidesUSD | 100mg Vial1 recorded offers | 100mg Vial · $75.00Stale observation · Checked Sep 30, 2026Supplier listing, GHK-Cu 100mg Vial, Blank Peptides, opens in a new tab |
| Amino ClubUSD | 50mg Vial · 100mg Vial · 25mg Spray3 recorded offers | 100mg Vial · $57.99Stale observation · Checked Sep 28, 2026Supplier listing, GHK-Cu 100mg Vial, Amino Club, opens in a new tab |
| Nova Peptide SupplyUSD | 50mg Vial · 100mg Vial2 recorded offers | 50mg Vial · $39.99Checked Oct 13, 2026Supplier listing, GHK-Cu 50mg Vial, Nova Peptide Supply, opens in a new tab |
| Amino USAUSD | 100mg Vial · 50mg Vial2 recorded offers | 100mg Vial · $50.00Checked Oct 13, 2026Supplier listing, GHK-Cu 100mg Vial, Amino USA, opens in a new tab |
| Cenexa LabsUSD | 100mg Vial · 50mg Vial · 200mg Powder3 recorded offers | 100mg Vial · $71.99Checked Oct 13, 2026Supplier listing, GHK-Cu 100mg Vial, Cenexa Labs, opens in a new tab |
Reference sources & further reading
- PubChem compound record 71587328 — chemical identity and structure.
- Wikipedia: Copper peptide GHK-Cu — Background encyclopedia; not a primary clinical source.
The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.
Search for additional research
These links run searches; their results have not been individually reviewed and can include unrelated compounds.
Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.
Related research profiles
5-Amino-1MQ
C10H11N2+
159.21 g/mol · PubChem CID 950107
3 selected publications · 0 human intervention studies
FOXO4-DRI
C228H388N86O64
5358 g/mol · PubChem CID 167312269
4 selected publications · 0 human intervention studies
Glutathione
C10H17N3O6S
307.33 g/mol · PubChem CID 124886
7 selected publications · 3 human intervention studies · 37 registered trials
Small molecule · highest stage: Phase 3
Humanin
C119H204N34O32S2
2687.2 g/mol · PubChem CID 16131438
1 selected publication · 0 human intervention studies
L-Carnitine
C7H15NO3
161.20 g/mol · PubChem CID 10917
8 selected publications · 0 human intervention studies · 40 registered trials
Small molecule · highest stage: Approved in at least one jurisdiction (ChEMBL phase 4)
MOTS-c
C101H152N28O22S2
2174.6 g/mol · PubChem CID 146675088
6 selected publications · 0 human intervention studies · 1 registered trial